Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis

Restarting OAC therapy after a major bleeding event in AF was associated with a positive clinical benefit when compared to non-restarting OAC, with a significant reduction in any thromboembolism and all-cause mortality.